Medical Journal of Australia

Papers
(The H4-Index of Medical Journal of Australia is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
COVID ‐19 acute respiratory distress syndrome ( ARDS ): clinical features and differences from typical pre‐ COVID 408
Isolation and rapid sharing of the 2019 novel coronavirus ( SARS ‐CoV‐2) from the first patient diagnosed with COVID ‐19 in Austra277
Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID ‐19 adult patient group250
Corticosteroid treatment of patients with coronavirus disease 2019 ( COVID ‐19)244
Mental health of people in Australia in the first month of COVID ‐19 restrictions: a national survey220
Surge capacity of intensive care units in case of acute increase in demand caused by COVID ‐19 in Australia102
Managing haematology and oncology patients during the COVID ‐19 pandemic: interim consensus guidance92
New Zealand's COVID‐19 elimination strategy81
Trajectories of depression and anxiety symptoms during the COVID‐19 pandemic in a representative Australian adult cohort76
COVID ‐19, children and schools: overlooked and at risk71
The quality of diagnosis and triage advice provided by free online symptom checkers and apps in Australia70
First Nations peoples leading the way inCOVID‐19 pandemic planning, response and management70
Australia's national COVID ‐19 primary care response70
The carbon footprint of pathology testing68
Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic66
Fewer presentations to metropolitan emergency departments during the COVID‐19 pandemic59
Gut microbiota‐derived trimethylamine N ‐oxide is associated with poor prognosis in patients with heart failure58
The 2020 special report of the MJA–Lancet Countdown on health and climate change: lessons learnt from Australia’s “Black Summer”57
Modelling the impact of relaxing COVID ‐19 control measures during a period of low viral transmission55
Effectiveness of COVID‐19 vaccines: findings from real world studies53
Cardiovascular disease and COVID ‐19: Australian and New Zealand consensus statement49
Clinical presentation and management ofCOVID‐1947
The probability of the 6‐week lockdown in Victoria (commencing 9 July 2020) achieving elimination of community transmission of SARS ‐CoV‐245
The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease45
COVID ‐19 precautions: easier said than done when patients are homeless45
Communicating with patients and the public about COVID‐19 vaccine safety: recommendations from the Collaboration on Social Science and Immunisation42
The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews41
Failures of quarantine systems for preventing COVID‐19 outbreaks in Australia and New Zealand40
FromSARStoCOVID‐19: the Singapore journey40
Chronic fatigue syndrome: progress and possibilities40
Phage therapy for severe bacterial infections: a narrative review37
Modelling the impact of COVID ‐19 on intensive care services in New South Wales36
Persistent symptoms up to four months after community and hospital‐managed SARS‐CoV‐2 infection36
Electronic cigarettes and health outcomes: umbrella and systematic review of the global evidence34
The deleterious effects of cannabis during pregnancy on neonatal outcomes34
Australian recommendations for the management of hepatocellular carcinoma: a consensus statement34
The prevalence and impact of unprofessional behaviour among hospital workers: a survey in seven Australian hospitals34
Potential indirect impacts of the COVID‐19 pandemic on children: a narrative review using a community child health lens34
0.036226034164429